SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
AMENDMENT NO. 4
TO
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Coram Healthcare Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock (par value $0.001 per share)
--------------------------------------------------------------------------------
(Title of Class of Securities)
218103109
----------------------------------------------
(CUSIP Number)
Steve Chaiken, Esq.
Goldman, Sachs & Co.
85 Broad Street
New York, New York 10004
(212) 902-1000
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
December 31, 2002
----------------------------------------------
(Date of Event which requires Filing of this Statement)
If a filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13(d)(1)(f) or 13(d)(1)(g), check the
following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Act") or otherwise be subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
-2-
--------------------
CUSIP NO. 218103109
--------------------
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Goldman Sachs Credit Partners L.P.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO [See Item 3.]
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
--------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES -----------------------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 2,045,346
EACH -----------------------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH -----------------------------------------------------
10. SHARED DISPOSITIVE POWER
2,045,346
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,045,346
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.0%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
-3-
--------------------
CUSIP NO. 218103109
--------------------
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Goldman Sachs Global Holdings L.L.C.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO [See Item 3.]
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES -----------------------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 2,045,346
EACH -----------------------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH -----------------------------------------------------
10. SHARED DISPOSITIVE POWER
2,045,346
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,045,346
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.0%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
OO
--------------------------------------------------------------------------------
-4-
--------------------
CUSIP NO. 218103109
--------------------
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Goldman Sachs Group, Inc.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS
AF - OO [See Item 3.]
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES -----------------------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 2,048,055
EACH -----------------------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH -----------------------------------------------------
10. SHARED DISPOSITIVE POWER
2,048,055
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,048,055
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.0%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
HC-CO
--------------------------------------------------------------------------------
-5-
--------------------
CUSIP NO. 218103109
--------------------
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Goldman, Sachs & Co.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS
AF - OO
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ X ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES -----------------------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 2,048,055
EACH -----------------------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH -----------------------------------------------------
10. SHARED DISPOSITIVE POWER
2,048,055
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,048,055
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.0%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
BD-PN-IA
--------------------------------------------------------------------------------
-6-
AMENDMENT NO. 4
TO
SCHEDULE 13D
RELATING TO THE COMMON STOCK OF
CORAM HEALTHCARE CORPORATION
Goldman Sachs Credit Partners L.P. ("GSCP"), Goldman Sachs Global Holdings
L.L.C. ("GSGH"), Goldman, Sachs & Co. ("GS&Co."), and The Goldman Sachs Group,
Inc. ("GS Group")1 hereby amend the statement on Schedule 13D filed on July 14,
1998 and most recently amended by Amendment No. 3 thereto, filed on January 4,
2001, relating to common stock, par value $0.001 per share (the "Common Stock"),
of Coram Healthcare Corporation (the "Company").
Item 1 is hereby amended and supplemented to reflect the following:
The principal executive offices of the Company are located at 1675
Broadway, Suite 900, Denver, Colorado.
Item 2 is amended and supplemented to reflect the following:
Schedule I included in Amendment No. 3 to the initial Schedule 13D
is hereby replaced in its entirety by Schedule I hereto, which is
incorporated herein by reference. Schedule II included in Amendment No. 3
to the initial Schedule 13D is hereby replaced in its entirety by Schedule
II hereto, which is incorporated herein by reference. Schedule III included
in the initial Schedule 13D, as supplemented by Schedule III included in
Amendment No. 3 to the initial Schedule 13D, is hereby supplemented by
Schedule III hereto, which is incorporated herein by reference.
Items 3, 4, 5 and 6 are hereby amended and supplemented to reflect the
following:
On March 30, 2001, pursuant to an amendment to the Risk
Participation Agreement between GSCP and Cerberus Partners L.P., Cerberus
Partners L.P. assigned to GSCP the Notes that Cerberus Partners L.P. held
subject to the Risk Participation Agreement. Such assignment did not result
in a change in GSCP's beneficial ownership as GSCP had reported beneficial
ownership of the Notes subject to the Risk Participation Agreement.
On December 31, 2001, GSCP exchanged approximately $9.54 million
of Series A Senior Subordinated Unsecured Notes (the "Series A Notes") and
approximately $0.86 million of accrued but unpaid interest on the Series A
--------
1 Neither the present filing nor anything contained herein shall be
construed as an admission that any Filing Person constitutes a "person"
for any purposes other than Section 13(d) of the Securities Exchange
Act of 1934 or that the Filing Persons constitute a "group" for any
purpose.
-7-
Notes and the Series B Senior Subordinated Convertible Unsecured Notes (the
"Series B Notes") for 86.1639 shares of Series A Preferred Stock, $0.001
par value per share of Coram, Inc. (the "Series A Preferred Stock") having
a liquidation preference of approximately $10.3 million.
In addition, on December 31, 2002, with the approval of the United
States Bankruptcy Court for the District of Delaware, GSCP exchanged
approximately $18.3 million of the Series A Notes, $3.3 million of accrued
but unpaid interest on the Series A Notes, $37.8 million of the Series B
Notes and $7.6 million of accrued but unpaid interest on the Series B Notes
for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc.
having a liquidation preference of approximately $66.9 million. As a result
of these transactions, GSCP now owns less than five percent of the Common
Stock of the Company.
As of December 31, 2002, Goldman Sachs may be deemed to have
beneficially owned 2,709 shares of Common Stock acquired in ordinary course
business activities. Schedule IV hereto, which is incorporated herein by
reference, describes the transactions in Common Stock effected by Goldman
Sachs during the period from November 1, 2002 to December 31, 2002, all of
which were effected in the over-the-counter market in the ordinary course
of business of Goldman Sachs.
In accordance with the Securities and Exchange Commission (the
"SEC") Release No. 34-39538 (January 12, 1998), this filing reflects the
securities beneficially owned by the investment banking division ("IBD") of
The Goldman Sachs Group, Inc. and its subsidiaries and affiliates
(collectively, "GSG"). This filing does not reflect securities, if any,
beneficially owned by any other operating unit of GSG. IBD disclaims
beneficial ownership of the securities beneficially owned by (i) any client
accounts with respect to which IBD or its employees have voting or
investment discretion, or both and (ii) certain investment entities, of
which IBD is the general partner, managing general partner or other
manager, to the extent interests in such entities are held by persons other
than IBD.
Item 7 is hereby amended and restated as follows:
Item 7. Material to be filed as Exhibits.
--------------------------------
(1) Not applicable.
(2) (a) Exchange Agreement, dated as of December 31,
2001, filed as Exhibit 99.1
(b) Amendment No.1 to Stockholder Agreement, dated as
of December 31, 2001, filed as Exhibit 99.2
(c) Exchange Agreement, dated as of December 31,
2002, filed as Exhibit 99.3
(d) Amendment No.2 to Stockholder Agreement, dated as
of December 31, 2002, filed as Exhibit 99.4
(3) (a) Amendment No. 5 to Securities Exchange Agreement,
dated as of December 31, 2001, filed as Exhibit 99.5
(b) Amendment No. 6 to Securities Exchange Agreement,
dated as of December 31, 2002, filed as Exhibit 99.6
-8-
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Statement is true, complete and
correct.
Dated: May 21, 2003
THE GOLDMAN SACHS GROUP, INC.
By:
-----------------------------------
Name: Roger S. Begelman
Title: Attorney-in-fact
GOLDMAN, SACHS & CO.
By:
-----------------------------------
Name: Roger S. Begelman
Title: Attorney-in-fact
GOLDMAN SACHS CREDIT
PARTNERS L.P.
By:
-----------------------------------
Name: Roger S. Begelman
Title: Attorney-in-fact
GOLDMAN SACHS GLOBAL
HOLDINGS L.L.C.
By:
-----------------------------------
Name: Roger S. Begelman
Title: Attorney-in-fact
-9-
EXHIBIT INDEX
Exhibit Description
Number
1. Not applicable
2A Exchange Agreement, dated as of December 31, 2001, filed as
Exhibit 99.1
2B Amendment No.1 to Stockholder Agreement, dated as of
December 31, 2001, filed as Exhibit 99.2
2C Exchange Agreement, dated as of December 31, 2002, filed as
Exhibit 99.3
2D Amendment No.2 to Stockholder Agreement, dated as of
December 31, 2002, filed as Exhibit 99.4
3A Amendment No. 5 to Securities Exchange Agreement, dated as of
December 31, 2001, filed as Exhibit 99.5
3B Amendment No. 6 to Securities Exchange Agreement, dated as of
December 31, 2002, filed as Exhibit 99.6
-10-
SCHEDULE I
----------
The name of each director of The Goldman Sachs Group, Inc. is set forth
below.
The business address of each person listed below is c/o Goldman, Sachs &
Co., 85 Broad Street, New York, NY 10004.
Each person is a citizen of the United States of America except for Lord
Browne of Madingley, who is a citizen of the United Kingdom. The present
principal occupation or employment of each of the listed persons is set forth
below.
Name Present Principal Occupation
--------------------------------------------------------------------------------
Henry M. Paulson, Jr. Chairman and Chief Executive Officer of
The Goldman Sachs Group, Inc.
John A. Thain President and Co-Chief Operating Officer of
The Goldman Sachs Group, Inc.
Lloyd C. Blankfein Vice Chairman of The Goldman Sachs Group,
Inc.
Lord Browne of Madingley Group Chief Executive of BP plc
John H. Bryan Retired Chairman and Chief Executive Officer
of Sara Lee Corporation
William W. George Retired Chairman and Chief Executive Officer
of Medtronic, Inc.
James A. Johnson Vice Chairman of Perseus, L.L.C.
Ruth J. Simmons President of Brown University
-11-
SCHEDULE II
-----------
The name, position and present principal occupation of each director and
executive officer of Goldman Sachs Global Holdings L.L.C., which is the sole
general partner of Goldman Sachs Credit Partners L.P., are set forth below.
The business address for all the directors and executive officers listed
below is 85 Broad Street, New York, New York 10004, except as follows: The
business address of Paul M. Russo is Peterborough Court, 133 Fleet Street,
London EC4A 2BB, England.
All executive officers and directors listed below are United States
citizens, except as follows: Sarah E. Smith is a citizen of the United Kingdom,
Veronica W. Foo is a citizen of Hong Kong (PRC) and Amol S. Naik is a citizen of
India.
Name Position Present Principal Occupation
--------------------------------------------------------------------------------
Gregory K. Palm Director/Secretary/ Managing Director of
Executive Vice President Goldman, Sachs & Co.
Esta E. Stecher Director/Secretary/ Managing Director of
Executive Vice President Goldman, Sachs & Co.
Dan H. Jester Director/Vice President Managing Director of
Goldman, Sachs & Co.
Henry M. Paulson, Jr. Chairman/ Managing Director of
Chief Executive Officer Goldman, Sachs & Co.
Lloyd C. Blankfein Vice Chairman Managing Director of
Goldman, Sachs & Co.
Robert S. Kaplan Vice Chairman Managing Director of
Goldman, Sachs & Co.
Robert K. Steel Vice Chairman Managing Director of
Goldman, Sachs & Co.
John A. Thain President Managing Director of
Goldman, Sachs & Co.
John L. Thornton President Managing Director of
Goldman, Sachs & Co.
David A. Viniar Chief Financial Officer/ Managing Director of
Executive Vice President Goldman, Sachs & Co.
Kevin W. Kennedy Executive Vice President Managing Director of
Goldman, Sachs & Co.
Raanan A. Agus Vice President Managing Director of
Goldman, Sachs & Co.
John G. Andrews Vice President Managing Director of
Goldman, Sachs & Co.
Craig W. Broderick Vice President Managing Director of
Goldman, Sachs & Co.
Robert J. Christie Vice President Managing Director of
Goldman, Sachs & Co.
Gary D. Cohn Vice President Managing Director of
Goldman, Sachs & Co.
Christopher A. Cole Vice President Managing Director of
Goldman, Sachs & Co.
E. Gerald Corrigan Vice President Managing Director of
Goldman, Sachs & Co.
Edward C. Forst Vice President Managing Director of
Goldman, Sachs & Co.
Richard A. Friedman Vice President Managing Director of
Goldman, Sachs & Co.
-12-
C. Douglas Fuge Vice President Managing Director of
Goldman, Sachs & Co.
David B. Heller Vice President Managing Director of
Goldman, Sachs & Co.
Stephen P. Hickey Vice President Managing Director of
Goldman, Sachs & Co.
Scott B. Kapnick Vice President Managing Director of
Goldman, Sachs & Co.
Peter S. Kraus Vice President Managing Director of
Goldman, Sachs & Co.
Kathleen M. Maloney Vice President Managing Director of
Goldman, Sachs & Co.
Andrew J. Melnick Vice President Managing Director of
Goldman, Sachs & Co.
Therese L. Miller Vice President Managing Director of
Goldman, Sachs & Co.
Eric M. Mindich Vice President Managing Director of
Goldman, Sachs & Co.
Donald Mullen Vice President Managing Director of
Goldman, Sachs & Co.
Philip D. Murphy Vice President Managing Director of
Goldman, Sachs & Co.
Daniel M. Neidich Vice President Managing Director of
Goldman, Sachs & Co.
Suzanne M. Nora Johnson Vice President Managing Director of
Goldman, Sachs & Co.
Terence M. O'Toole Vice President Managing Director of
Goldman, Sachs & Co.
Scott S. Prince Vice President Managing Director of
Goldman, Sachs & Co.
John F. W. Rogers Vice President Managing Director of
Goldman, Sachs & Co.
Pamela P. Root Vice President Managing Director of
Goldman, Sachs & Co.
Paul M. Russo Vice President Managing Director of
Goldman Sachs International
Michael D. Ryan Vice President Managing Director of
Goldman, Sachs & Co.
Eric S. Schwartz Vice President Managing Director of
Goldman, Sachs & Co.
Howard A. Silverstein Vice President Managing Director of
Goldman, Sachs & Co.
Sarah E. Smith Vice President/ Managing Director of
Controller Goldman, Sachs & Co.
Robert T. Wagner Vice President Managing Director of
Goldman, Sachs & Co.
John S. Weinberg Vice President Managing Director of
Goldman, Sachs & Co.
John Winkelried Vice President Managing Director of
Goldman, Sachs & Co.
Carol A. Cortorillo Assistant Vice President Vice President of
Goldman, Sachs & Co.
Thomas J. McAdam Assistant Vice President Managing Director of
Goldman, Sachs & Co.
-13-
David M. Weil Treasurer Managing Director of
Goldman, Sachs & Co.
Steven M. Bunson Assistant Secretary Managing Director of
Goldman, Sachs & Co.
Kenneth L. Josselyn Assistant Secretary Managing Director of
Goldman, Sachs & Co.
Russell E. Makowsky Assistant Secretary Managing Director of
Goldman, Sachs & Co.
James B. McHugh Assistant Secretary Vice President of
Goldman, Sachs & Co.
Beverly L. O'Toole Assistant Secretary Vice President of
Goldman, Sachs & Co.
Ellen R. Porges Assistant Secretary Managing Director of
Goldman, Sachs & Co.
Howard B. Surloff Assistant Secretary Managing Director of
Goldman, Sachs & Co.
Elizabeth E. Beshel Assistant Treasurer Managing Director of
Goldman, Sachs & Co.
Andrew B. Fontein Assistant Treasurer Vice Prsident of
Goldman, Sachs & Co.
Veronica W. Foo Assistant Treasurer Vice Prsident of
Goldman, Sachs & Co.
Susan Healy Assistant Treasurer Vice Prsident of
Goldman, Sachs & Co.
Amol S. Naik Assistant Treasurer Vice Prsident of
Goldman, Sachs & Co.
Scott L. Wertheimer Assistant Treasurer Vice Prsident of
Goldman, Sachs & Co.
-14-
SCHEDULE III
------------
On April 6, 2000, in connection with an industry-wide investigation by the
Securities and Exchange Commission (the "SEC") relating to the pricing of
government securities in advance refunding transactions, Goldman, Sachs & Co.
("Goldman Sachs") joined in a global settlement resolving the SEC investigation
as well as a related qui tam lawsuit purportedly brought on behalf of the United
States entitled United States ex rel. Lissack v. Goldman, Sachs & Co., et al.,
95 Civ. 1363 (S.D.N.Y.)(BSJ). Pursuant to the settlement, without admitting or
denying the findings, Goldman Sachs consented to the issuance of an SEC
administrative order (SEA Rel. No. 42640) which, among other things, found that
Goldman Sachs had violated Sections 17(a)(2) and (3) of the Securities Act of
1933 in connection with such pricing of government securities, required Goldman
Sachs to cease and desist from violating such provisions, and ordered Goldman
Sachs to make payments totaling approximately $5.1 Million to the U.S. Treasury
and $104,000 to two municipalities. Under the global settlement, the qui tam
lawsuit was dismissed with prejudice, and the Internal Revenue Service agreed
not to challenge the tax-free nature of the refundings by virtue of the pricing
of such securities.
In November 2002, the SEC, the National Association of Securities Dealers
("NASD") and the New York Stock Exchange, Inc. ("NYSE") alleged that five broker
dealers, including Goldman Sachs, violated Section 17(a) of the Exchange Act and
Rule 17a-4 hereunder, NYSE Rules 440 and 342 and NASD Rules 3010 and 3110 by
allegedly failing to preserve electronic mail communications for three years
and/or to preserve electronic mail communications for the first two years in an
accessible place, and by allegedly having inadequate supervisory systems and
procedures in relation to the retention of electronic mail communications.
Without admitting or denying the allegations, the five broker dealers, including
Goldman Sachs, consented to censure by the SEC, NASD and NYSE and to the
imposition of a cease-and-desist order by the SEC and Goldman Sachs paid a total
fine of $1,650,000 ($550,000 each to the SEC, NASD and NYSE). Goldman Sachs also
undertook to review its procedures regarding the preservation of electronic mail
communications for compliance with the federal securities laws and regulations
and the rules of the NASD and NYSE, and to confirm within a specified period of
time that it has established systems and procedures reasonably designed to
achieve compliance with those laws, regulations and rules.
-15
SCHEDULE IV
-----------
Purchases Sales Price Trade Date Settlement Date
--------- ----- ----- ---------- ---------------
10,000 0.480 11/4/02 11/7/02
7,500 0.455 11/7/02 11/13/02
4,000 0.480 11/8/02 11/14/02
1,000 0.520 11/12/02 11/15/02
8,450 0.520 11/12/02 11/15/02
8,500 0.520 11/12/02 11/15/02
150 0.520 11/12/02 11/15/02
125 0.465 11/14/02 11/19/02
1,000 0.465 11/18/02 11/21/02
1,000 0.465 11/18/02 11/21/02
428 0.460 11/19/02 11/22/02
630 0.490 11/20/02 11/25/02
100 0.480 11/20/02 11/25/02
3,000 0.530 11/22/02 11/27/02
31 0.530 11/25/02 11/29/02
89 0.530 11/27/02 12/3/02
2,500 0.510 11/27/02 12/3/02
63 0.450 12/2/02 12/5/02
400 0.480 12/4/02 12/9/02
300 0.450 12/9/02 12/12/02
1,220 0.450 12/10/02 12/13/02
1,000 0.480 12/12/02 12/17/02
1,300 0.460 12/12/02 12/17/02
500 0.420 12/13/02 12/18/02
1,400 0.435 12/13/02 12/18/02
146 0.410 12/16/02 12/19/02
4,000 0.430 12/17/02 12/20/02
400 0.430 12/17/02 12/20/02
100 0.430 12/18/02 12/23/02
243 0.430 12/18/02 12/23/02
63 0.430 12/18/02 12/23/02
252 0.430 12/19/02 12/24/02
33 0.430 12/20/02 12/26/02
4,270 0.430 12/23/02 12/27/02
6,400 0.440 12/24/02 12/30/02
33 0.440 12/24/02 12/30/02
5,000 0.450 12/24/02 12/30/02
5,000 0.450 12/24/02 12/30/02
125 0.480 12/27/02 1/2/03
67 0.500 12/30/02 1/3/03
200 0.500 12/30/02 1/3/03
63 0.500 12/30/02 1/3/03
2,500 0.520 12/30/02 1/3/03
9 0.480 12/30/02 1/3/03
900 0.480 12/30/02 1/3/03
1,000 0.480 12/30/02 1/3/03
10,000 0.600 12/31/02 1/6/03
10,000 0.600 12/31/02 1/6/03
1,000 0.520 12/31/02 1/6/03
63 0.520 12/31/02 1/6/03
1,000 0.540 12/31/02 1/6/03
315 0.540 12/31/02 1/6/03
2,500 0.610 12/31/02 1/6/03
2,500 0.630 12/31/02 1/6/03
5,000 0.630 12/31/02 1/6/03
2,500 0.620 12/31/02 1/6/03
150 0.600 12/31/02 1/6/03
519 0.630 12/31/02 1/6/03
10,000 0.630 12/31/02 1/6/03
10,000 0.630 12/31/02 1/6/03
5,000 0.630 12/31/02 1/6/03
7,000 0.630 12/31/02 1/6/03
1,715 0.630 12/31/02 1/6/03
47 0.630 12/31/02 1/6/03
16